| Pharmaceuticals Industry | Healthcare Sector | Rosella C. Perri CEO | EXPM Exchange | 277253100 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Eastgate Biotech Corp. is a development stage company that specializes in creating novel formulations of natural compounds and pharmaceutical products. Initially founded in 1999 as Eastgate Acquisitions Corporation, the company underwent a name change in December 2014 to better reflect its focus on biotechnological advancements. Headquartered in Toronto, Canada, Eastgate Biotech Corp. is dedicated to developing a diverse range of products, from pharmaceuticals aimed at treating acute medical conditions to natural products and dietary supplements designed for everyday health support. Notably, the company has entered into a collaboration with Biotech Corp. to develop a vaccine against COVID-19, showcasing its commitment to addressing contemporary global health challenges.